Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010

Eurosurveillance

Volumn 18, Issue 2, 2013, Pages

  Caini, S ^a,b   Hajdu, A ^a   Kurcz, A ^a   Borocz K ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CHILD; DISEASE SURVEILLANCE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUNGARY; ICD-10; INCIDENCE; INFANT; INFECTION CONTROL; KLEBSIELLA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANT ORGANISM; ORGANISMS; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STENOTROPHOMONAS MALTOPHILIA; SURGICAL INFECTION;

EID: 84872324662     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ben-David D, Novikov I, Mermel LA. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible Staphylococcus aureus bloodstream infection? Infect Control Hosp Epidemiol. 2009;30(5):453-60.
2. Centers for Disease Control and Prevention (CDC). National Healthcare Safety Network (NHSN). Atlanta: CDC. [Accessed: 19 Dec 2012]. Available from: http://www.cdc.gov/nhsn/
3. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ) [German National Reference Center for the Surveillance of Nosocomial Infections]. MRSA-KISS Reference Data, 2009. Berlin: NRZ. [Accessed: 19 Dec 2012]. Available from: http://www.nrz-hygiene.de/en/surveillance/hospital-infection-surveillance-system/mrsa-kiss/
4. Geffers C, Gastmeier P. Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch Arztebl Int. 2011;108(6):87-93.
5. Centres de Coordination de la Lutte contre les Infections Nosocomiales (CCLIN) [Infection Control Coordinating Centres]. Homepage. Nancy: CCLIN. [Accessed: 19 Dec 2012]. French. Available from: http://www.cclin-france.fr/
6. Carlet J, Astagneau P, Brun-Buisson C, Coignard B, Salomon V, Tran B, et al. French national program for prevention of healthcare associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol. 2009;30(8):737-45.
7. Transatlantic Taskforce on Antimicrobial Resistance (TATFAR). Recommendations for future collaboration between the U.S. and EU. TATFAR; 2011. Available from: http://www.cdc.gov/drugresistance/pdf/tatfar-report.pdf
8. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. Stockholm: ECDC; 2011. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=767
9. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2011. Available from: http://ecdc.europa.eu/en/publications/Publications/1111_SUR_AMR_data.pdf.pdf
10. Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. Euro Surveill. 2008;13(4):pii=8023. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8023
11. Durante-Mangoni E, Zarrilli R. Global spread of drug resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 2011; 6(4):407-22.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.
13. Országos Epidemiológiai Központ [National Center for Epidemiology]. Tájékoztató a Nemzeti Nosocomialis Surveillance Rendszer (NNSR) és a Nemzeti Bakteriológiai Surveillance (NBS) 2010. évi eredményeiro{double acute}l [Annual Reports of the National Surveillance System for Nosocomial Infections (NNSR) and the National Bacteriological Surveillance System (NBS), 2010] Epinfo. 2011;6. supplement. Hungarian. Available from: http://www.oek.hu/oek.web?to=839,1890&nid=964&pid=1&lang=hun
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. Wayne: CLSI; 2005.
15. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI Wayne: CLSI; 2006.
16. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. Wayne: CLSI; 2007.
17. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. Wayne: CLSI; 2008.
18. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. Wayne: CLSI; 2009.
19. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. Wayne: CLSI; 2010.
20. Országos Egészségbiztosítási Pénztár [National Health Insurance Fund Administration of Hungary]. Kórházi Ágyszám-és Betegforgalmi Kimutatás. [Hospital beds and patient turnover account]. [Date of access: 19 Dec 2012] Hungarian. Available from http://www.gyogyinfok.hu/magyar/archiv.html
21. Puhto T, Ylipalosaari P, Ohtonen P, Syrjala H. Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards. Infection. 2011;39(3):217-23.
22. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveill. 2008;13(47):pii=19044. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19044
23. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia in England. J Antimicrob Chemother. 2009;64 Suppl 1:i11-7.
24. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010;304(6):641-8.
25. Health Protection Agency (HPA). Quarterly epidemiological commentary: mandatory MRSA, MSSA and E. coli bacteraemia, and C.difficile infection data (up to July-September 2012). London: HPA; 13 Dec 2012. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1284473407318
26. Smittskyddsinstitutet (SMI) [Swedish Institute for Communicable Disease Control]. Statistik för meticillinresistenta gula stafylokocker (MRSA). [Statistics for meticillin-resistant Staphylococcus aureus (MRSA)) Swedish. Available from: http://www.smittskyddsinstitutet.se/statistik/ meticillinresistenta-gula-stafylokocker-mrsa/
27. Elstrøm P, Kacelnik O, Bruun T, Iversen B, Hauge SH, Aavitsland P. Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010. J Hosp Infect. 2012;80(1):36-40.
28. Simor AE, Gilbert NL, Gravel D, Mulvey MR, Bryce E, Loeb M, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007. Infect Control Hosp Epidemiol. 2010;31(4):348-56.
29. Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, et al. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis. 2010;51(8):925-8.
30. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2009;30(12):1186-92.
31. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, et al. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2010;31(1):47-53.
32. Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009;30(2):184-6.
33. Lee K, Kim MN, Kim JS, Hong HL, Kang JO, Shin JH, et al. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J. 2011;52(5):793-802.
34. European Surveillance of Antimicrobial Consumption (ESAC). ESAC Yearbook 2009. Antwerp: ESAC. [Accessed: 19 Dec 2012]. ISBN: 9789057283307. Available from: http://www.ecdc.europa.eu/en/activities/surveillance/ESAC-Net/publications/Pages/documents.aspx
35. Adriaenssens N, Coenen S, Versporten A, Muller A, Vankerckhoven V, Goossens H; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66Suppl 6:vi71-77. doi: 10.1093/jac/dkr459.
36. Benko R, Matuz M, Peto Z, Bogár L, Viola R, Doró P, et al. Variations and determinants of antibiotic consumption in Hungarian adult intensive care units. Pharmacoepidemiol Drug Saf. 2012;21(1):104-9.
37. 20/2009. (VI. 18.) EüM rendelet az egészségügyi ellátással összefüggo{double acute} ferto{double acute}zések megelo{double acute}zéséro{double acute}l, e tevékenységek szakmai minimumfeltételeiro{double acute}l és felügyeletéro{double acute}l. [Decree of the Ministry of Health on prevention of healthcare-associated infections, related professional minimum requirements and control activities]. [Accessed: 18 Dec 2012]. Hungarian. Available from: http://www.complex.hu/jr/gen/hjegy_doc.cgi?docid=A0900020.EUM
38. Országos Epidemiológiai Központ [National Center for Epidemiology]. Módszertani levél a Methicillin/Oxacillin Rezisztens Staphylococcus Aureus (MRSA) ferto{double acute}zések megelo{double acute}zésére. [Methodological letter on the prevention of infections caused by meticillin/oxacillin-resistant Staphylococcus aureus (MRSA)].Epinfo. 2001;8(5. különszám). Hungarian. Available from: http://www.oek.hu/oek.web?nid=444&pid=2&to=16&lang=hun
39. Országos Epidemiológiai Központ [National Center for Epidemiology]. A széles spektrumú béta-laktamázokat termelo{double acute} Gram-negatív baktériumok jelento{double acute}sége és az általuk okozott nosocomialis járványok leküzdése. [The importance of extended-spectrum beta-lactamase producing Gram-negative bacteria and control of such nosocomial outbreaks]. Epinfo. 2002;30:349-52. Hungarian. Available from: http://www.oek.hu/oek.web?nid=1080&pid=1
40. Országos Epidemiológiai Központ [National Center for Epidemiology]. Vancomycin-rezisztens Enterococcus (VRE) ferto{double acute}zések megelo{double acute}zése az egészségügyi intézményekben. [Prevention of infections caused by vancomycin-resistant enterococci (VRE) in healthcare facilities]. Epinfo. 2004;42:522-26. Hungarian. Available from: http://www.oek.hu/oek.web?nid=1080&pid=1
41. Országos Epidemiológiai Központ [National Center for Epidemiology]. A multirezisztens kórokozók felügyelete az egészségügyi intézményekben. [Control of multidrug-resistant pathogens in healthcare facilities]. Epinfo. 2007;10-11:89-98. Hungarian. Available from: http://www.oek.hu/oek.web?nid=1080&pid=1
42. Országos Epidemiológiai Központ [National Center for Epidemiology]. Ajánlás a hVISA/VISA azonosítása esetén szükséges teendo{double acute}kro{double acute}l és a kórokozó terjedésének megelo{double acute}zését célzó infekciókontroll intézkedésekro{double acute}l. [Recommendations on actions required upon the detection of hVISA/VISA and on infection control measures to prevent its spread]. Epinfo. 2008;15:173-6. Hungarian. Available from: http://www.oek.hu/ oek.web?to=1493,1494,1495,1480&nid=41&pid=8&lang=hun
43. Országos Epidemiológiai Központ [National Center for Epidemiology]. A S. aureus vancomycinnel szembeni rezisztenciája. [Vancomycin resistance of S. aureus]. Epinfo. 2008;15:177-9. Hungarian. Available from: http://www.oek.hu/oek.web?to=1493,1494,1495,1480&nid=41&pid=8&lang=hun
44. Országos Epidemiológiai Központ [National Center for Epidemiology]. Ajánlás a karbapenemáz-termelo{double acute} Enterobacteriaceae törzsek azonosítására és terjedésük megelo{double acute}zésére az egészségügyi intézményekben. [Recommendation on identification of carbapenemase-producing enterobacteriaceae strains and prevention of their spread in healthcare facilities]. Epinfo. 2011;47:541-50. Hungarian. Available from: http://www.oek.hu/oek.web?to=839,1866&nid=41&pid=11&lang=hun